March 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
The miRNA sequencing and assay market is growing with advancements in next-gen sequencing (NGS) to explore miRNA's role in gene regulation and disease. Recent funding rounds, like aceRNA's $6.1M raise and Regulus' $100M deal, highlight innovations. AI integration, like Biostate AI's RNAseq tools, further accelerates research....
November 01, 2025
RNA-based therapies are rapidly growing, offering new treatment possibilities for diseases like cancer, neurological disorders, and infections. Recent advancements in mRNA, ASO, and siRNA technologies have led to new approvals, with more in development. These therapies offer targeted, risk-free solutions with broad potential....
November 01, 2025
Based on market forecasts, the global cell counting market, projected at USD 10.24 billion in 2024, is expected to reach USD 22.85 billion by 2034, growing at a CAGR of 8.41% over the forecast period. The cell counting market is growing because incorporating cell counts into flow cytometry is an easy way to improve test results and potentially save...
November 01, 2025
According to market projections, the glycomics sector is expected to grow from USD 2.21 billion in 2024 to USD 8.66 billion by 2034, reflecting a CAGR of 14.64%. The glycomics field is growing significantly due to its applications in drug discovery, disease diagnosis, therapeutics, and personalized medicine....
November 01, 2025
Induced pluripotent stem cells (iPSCs) are versatile cells derived from adult skin or blood, capable of transforming into any cell type. Widely used in regenerative medicine, disease modeling, and drug discovery, iPSCs are driving innovation, fueled by rising R&D and investment in stem cell therapies....
November 01, 2025
The macular edema and macular degeneration market is growing rapidly due to the prevalence of diabetic retinopathy and advancements in treatments like gene therapy and AI-based devices. Innovations, including FDA-approved EYLEA HD and OrCam MyEye, highlight progress in addressing vision loss globally....
November 01, 2025
Tissue clearing is a technique that makes biological tissues transparent for better microscopy visualization. Combined with fluorescent labeling and advanced imaging, it enables detailed 3D analysis. AI enhances this process by improving tissue imaging, data analysis, and accelerating research in fields like cancer and neurology....
November 01, 2025
The multiomics market is advancing with key funding rounds: PrognomiQ raised $34M (Nov 2024) to enhance disease monitoring, and Freenome secured $254M (Feb 2024) for early cancer detection tests. AI integration drives breakthroughs in data analysis, precision medicine, and drug discovery (e.g., MultiOmic Health)....
November 01, 2025
G-protein-coupled receptors (GPCRs) are critical targets in treating various diseases, including cardiovascular conditions. Recent investments, such as Superluminal's $120 million Series A funding and St. Jude's research collaboration, highlight the growing focus on developing innovative GPCR-targeting therapies, including AI-driven drug discovery....
November 01, 2025
Gene expression involves converting genetic information into functional RNA or proteins, vital in healthcare for disease insights and drug discovery. North America leads the market, driven by funding and advancements, while Asia-Pacific grows rapidly with government support and biopharma innovations....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com